Genetix Biotherapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Genetix Biotherapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Genetix Biotherapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Genetix Biotherapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Genetix Biotherapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US11834668B2 | Grant | Compounds for improved viral transduction | C12N15/86; C12N15/867; C12N2501/02; C12N2510/00; C12N2740/16043; C12N2810/6081; C12N5/0647; A61K2035/124; A61K38/46 | December 05, 2023 |
| CA2951044C | Grant | Improved t cell compositions | C12N2501/2302; C12N2501/51; C12N2501/515; C12N2501/599; C12N2501/727; C12N2501/999; C12N2510/00; C12N5/0636; A61K35/17; A61P1/18; A61P11/00; A61P13/10; A61P15/00; A61P17/00; A61P25/00; A61P35/00; A61P35/02; C07K14/7051; C07K14/70517; C07K14/70521; C07K16/2878; C07K2319/02; C07K2319/03; C07K2319/74 | October 03, 2023 |
| CA2946585C | Grant | Mnd promoter chimeric antigen receptors | C12N15/86; C12N15/867; C12N2740/15043; C12N5/0636; C12N7/00; A61K2039/505; A61K2039/5158; A61K39/0011; A61K39/001104; A61K39/001106; A61K39/001109; A61K39/001112; A61K39/001113; A61K39/001119; A61K39/001122; A61K39/001124; A61K39/001128; A61K39/001129; A61K39/001138; A61K39/00115; A61K39/001166; A61K39/001168; A61K39/00117; A61K39/001171; A61K39/001174; A61K39/00118; A61K39/001182; A61K39/001184; A61K39/001186; A61K39/001188; A61K39/001189; A61K39/001193; A61K39/001195; A61K48/00; A61P35/00; A61P35/02; A61P37/04; A61P43/00; C07K14/7051; C07K14/70517; C07K14/70578; C07K16/2803; C07K16/30; C07K2317/524; C07K2317/526; C07K2317/622; C07K2319/00; C07K2319/02; C07K2319/03 | September 19, 2023 |
| US20230279145A1 | Application | Sickled beta globin antibodies | C07K16/18; C07K16/34; C07K2317/34; C07K2317/565; C07K2317/622; G01N33/721 | September 07, 2023 |
| AU2017217813B2 | Grant | Vcn enhancer compositions and methods of using the same | C12N15/86; C12N2510/00; C12N2740/15041; C12N5/0647; C12N5/10; C12Y301/06013; C12Y302/01076; C12Y304/14009; C12Y305/04004; A61K35/28; A61P25/00; A61P25/02; A61P25/08; A61P25/28; A61P37/02; A61P5/38; A61P7/00; A61P7/06; C07K14/7155 | August 03, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer